SCHEMBL2319362

SCHEMBL2319362

O=C(O)CC1CCN2C(=O)CCC2C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.39
POLB P06746 1/20 0.39
MAPT P10636 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
AKR1C3 P42330 2/20 0.36
AKR1C2 P52895 2/20 0.36
SLC6A1 P30531 2/20 0.36
GABRA5 P31644 2/20 0.36
GABRB2 P47870 2/20 0.36
SLC6A12 P48065 2/20 0.36
SLC6A11 P48066 2/20 0.36
SLC6A13 Q9NSD5 2/20 0.36
GABRA1 P14867 1/20 0.36
GABRR1 P24046 1/20 0.36
GABRA4 P48169 1/20 0.36
ADCY5 O95622 1/20 0.35
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
HTT P42858 1/20 0.32
KHK P50053 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12283890 1.00 ALDH1A1 (0.39) ALDH1A1POLBMAPTTDP1AKR1C3
SCHEMBL12283793 0.80 AKR1C3 (0.43) ALDH1A1POLBMAPTAKR1C3AKR1C2
SCHEMBL2318844 0.80 AKR1C3 (0.43) ALDH1A1POLBMAPTAKR1C3AKR1C2
SCHEMBL19277298 0.79
SCHEMBL24667087 0.78 TDP1 (0.36) ALDH1A1TDP1AKR1C3AKR1C2
SCHEMBL22052762 0.78 TDP1 (0.36) ALDH1A1TDP1AKR1C3AKR1C2
SCHEMBL22052763 0.78 TDP1 (0.36) ALDH1A1TDP1AKR1C3AKR1C2
SCHEMBL21739121 0.78 TDP1 (0.36) ALDH1A1TDP1AKR1C3AKR1C2
SCHEMBL21740354 0.75 CHRM2 (0.35) ALDH1A1TDP1AKR1C3AKR1C2OPRM1
SCHEMBL2315449 0.75 ALDH1A1 (0.34) ALDH1A1POLBMAPTTDP1SLC6A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102272120-B Biologically active amides LUNDBECK & CO AS H 2013-12-25 CN disclosed
CN-102272120-A Biologically active amides 2011-12-07 CN disclosed
US-20110230497-A1 BIOLOGICALLY ACTIVE AMIDES H. LUNDBECK A/S (DK) 2011-09-22 US disclosed
EP-2352730-A2 BIOLOGICALLY ACTIVE AMIDES H. Lundbeck A/S (DK) 2011-08-10 EP disclosed
WO-2010053861-A2 BIOLOGICALLY ACTIVE AMIDES H. LUNDBECK A/S (DK) 2010-05-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230497-A1 BIOLOGICALLY ACTIVE AMIDES NPY5R, NPY1R, NPY2R ALDH1A1 3024/4885POLB 4553/4885MAPT 2111/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.